Chennai: In a setback to the development of COVID-19 vaccines in India, a 40-year-old man has sent a legal notice to…
London: British pharma company AstraZeneca said on Saturday it has restarted COVID-19 vaccine trial after getting the go-ahead from the…
New Delhi: With pharma giant AstraZeneca pausing the Oxford COVID-19 vaccine candidate's trials in other countries, the Serum Institute of…
London: Two days after the worrying news of the clinical trials of Oxford-AstraZeneca's COVID vaccine candidate being halted, the drugmaker…
London: In a bit of a setback, a phase 3 clinical study of the COVID-19 vaccine developed by the University…
Pune: Serum Institute of India’s (SII) phase 2 trial of Oxford's COVID-19 vaccine candidate is set to commence on Tuesday.…
New Delhi: The phase III trials of the Oxford vaccine for COVID-19 are likely to start this week in India.…
New Delhi: The Drugs Controller General of India (DCGI) has given green signal to Pune-based Serum Institute of India (SII)…
New Delhi: Around 160 vaccines currently are being developed for COVID-19, and 25 of these are in human trial phases,…
London: The COVID-19 experimental vaccine by AstraZeneca and UK's Oxford University has been found to be safe and has produced…